BRIEF-Acorda Therapeutics says to discontinue development of PLUMIAZ By: Reuters: Company News May 20, 2016 at 06:22 AM EDT * Acorda to discontinue development of plumiaz for treatment of epilepsy seizure clusters Read More >> Related Stocks: Acorda Therapeutics